DE602007002625D1 - Verwendung von botulintoxin zur linderung von hodenschmerzen - Google Patents

Verwendung von botulintoxin zur linderung von hodenschmerzen

Info

Publication number
DE602007002625D1
DE602007002625D1 DE602007002625T DE602007002625T DE602007002625D1 DE 602007002625 D1 DE602007002625 D1 DE 602007002625D1 DE 602007002625 T DE602007002625 T DE 602007002625T DE 602007002625 T DE602007002625 T DE 602007002625T DE 602007002625 D1 DE602007002625 D1 DE 602007002625D1
Authority
DE
Germany
Prior art keywords
pain
botulintoxin
bumble
reduction
testicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007002625T
Other languages
English (en)
Inventor
Gregory F Brooks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE602007002625D1 publication Critical patent/DE602007002625D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE602007002625T 2006-05-02 2007-04-26 Verwendung von botulintoxin zur linderung von hodenschmerzen Active DE602007002625D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/417,335 US7811586B2 (en) 2006-05-02 2006-05-02 Methods for alleviating testicular pain
PCT/US2007/067521 WO2007143294A1 (en) 2006-05-02 2007-04-26 Use of botulinum toxin for alleviating testicular pain

Publications (1)

Publication Number Publication Date
DE602007002625D1 true DE602007002625D1 (de) 2009-11-12

Family

ID=38461002

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007002625T Active DE602007002625D1 (de) 2006-05-02 2007-04-26 Verwendung von botulintoxin zur linderung von hodenschmerzen

Country Status (6)

Country Link
US (1) US7811586B2 (de)
EP (1) EP2012811B1 (de)
AT (1) ATE444076T1 (de)
DE (1) DE602007002625D1 (de)
ES (1) ES2330692T3 (de)
WO (1) WO2007143294A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US8105611B2 (en) * 2005-06-17 2012-01-31 Allergan, Inc. Treatment of autoimmune disorder with a neurotoxin
DK2161033T3 (da) * 2008-09-09 2013-08-05 Susanne Dr Grafe Botulinustoxin til at indføre midlertidig infertilitet i et hvirveldyr (f.eks. et menneske)
RU2454170C1 (ru) * 2011-02-21 2012-06-27 Федеральное государственное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения и социального развития Российской Федерации Способ лечения спастичности мышц у больных с позвоночно-спинномозговой травмой
ES2424294B1 (es) 2012-03-22 2014-07-21 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
EP2649985A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (III)
EP2649984A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose
EP2649983A1 (de) 2012-04-13 2013-10-16 Lipotec, S.A. Verbindungen zur Hemmung neuronaler Exozytose (II)
EP2836193B1 (de) 2012-04-13 2018-01-31 Lubrizol Advanced Materials, Inc. Verbindungen zur hemmung neuronaler exozytose (ii)
ES2612237T3 (es) 2013-03-22 2017-05-12 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, membranas de mucosas y/o uñas

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5427291A (en) 1993-09-21 1995-06-27 Smith; David S. Ski carrier and method employing same
EP0737074B1 (de) 1993-12-28 2001-08-01 Allergan Sales, Inc. Botulinumtoxine zur behandlung von hyperhydrosis
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
DK0758900T3 (da) 1994-05-09 2002-07-29 William J Binder Botulinumtoksin til reduktion af migræne-hovedpinesmerter
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US7455845B2 (en) 1997-07-15 2008-11-25 The Regents Of The University Of Colorado Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
US7470431B2 (en) 1997-07-15 2008-12-30 The Regents Of The University Of Colorado Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
PT1011695E (pt) 1997-07-15 2006-07-31 Univ Colorado Utilizacao de terapia com neurotoxina para tratamento de doencas da prostata
US9066943B2 (en) 1997-07-15 2015-06-30 The Regents Of The University Of Colorado Use of botulinum toxin therapy for treatment of urological neurological conditions
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6143306A (en) 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6358513B1 (en) 2000-02-15 2002-03-19 Allergan Sales, Inc. Method for treating Hashimoto's thyroiditis
US6328977B1 (en) 2000-02-22 2001-12-11 Allergan Sales, Inc. Method for treating hyperparathyroidism
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6306403B1 (en) 2000-06-14 2001-10-23 Allergan Sales, Inc. Method for treating parkinson's disease with a botulinum toxin
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US6776991B2 (en) 2002-06-26 2004-08-17 Allergan, Inc. Methods for treating priapism

Also Published As

Publication number Publication date
ATE444076T1 (de) 2009-10-15
EP2012811B1 (de) 2009-09-30
US20070259000A1 (en) 2007-11-08
EP2012811A1 (de) 2009-01-14
ES2330692T3 (es) 2009-12-14
WO2007143294A1 (en) 2007-12-13
US7811586B2 (en) 2010-10-12

Similar Documents

Publication Publication Date Title
DE602007002625D1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
NZ603717A (en) Suture line administration technique using botulinum toxins
WO2007100675A3 (en) Collagenase for treating cellulite
TW200503751A (en) Methods for treating sinus headache
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
SG158112A1 (en) Hepatocyte growth factor (hgf) binding proteins
WO2010017556A8 (en) Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue
TW200738262A (en) Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
BRPI0418745A (pt) anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente
EP4257178A3 (de) Rückenmarksmodulationssyteme zur Induzierung von parästhetischen und anästhetischen Effekten
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
SG173683A1 (en) Methods and systems for diagnosis and treatment of a defined condition, and methods for operating such systems
MX2009007053A (es) Inhibidores de poli (adp-ribosa) polimerasa.
EA200971053A1 (ru) Способы лечения кожных язв
WO2007126999A3 (en) System and method for microablation of tissue
CA2899775C (en) Compositions and methods for pain relief without numbness
MX357071B (es) Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes.
WO2009130600A3 (en) Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
WO2012068339A3 (en) Methods of treating cancer
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
WO2007100590A3 (en) Methods for treating cellulite
DK1869185T3 (da) Konjugat med P21-protein til kræftbehandling
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
DK1778834T5 (da) Fremgangsmåder til anvendelse af regenerative celler i behandlingen af renale sygdomme og lidelser
UA88697C2 (ru) Способ лечения больных с ожоговыми ранами

Legal Events

Date Code Title Description
8364 No opposition during term of opposition